Cargando…

Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis

The prognostic value of E-cadherin expression in patients with breast cancer has been studied for years, yet results remain controversial. We thus performed a comprehensive evaluation of the association between E-cadherin expression and prognosis through a meta-analysis. The databases PubMed, Embase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhan, Yin, Songcheng, Zhang, Lei, Liu, Weiguang, Chen, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369975/ https://www.ncbi.nlm.nih.gov/pubmed/28147315 http://dx.doi.org/10.18632/oncotarget.14860

Ejemplares similares

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
por: Li, Zhan, et al.
Publicado: (2017)

An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer
por: Yu, LiLi, et al.
Publicado: (2017)

Correction: An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer
por: Yu, LiLi, et al.
Publicado: (2018)

Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis
por: Yin, Songcheng, et al.
Publicado: (2017)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
por: Noh, Myung-Giun, et al.
Publicado: (2017)

Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Chen, Jiang, et al.
Publicado: (2014)

E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis
por: Dai, Chencheng, et al.
Publicado: (2017)

Prognostic significance of E-cadherin and ZEB1 expression in intraductal papillary mucinous neoplasm
por: Chang, Ye Rim, et al.
Publicado: (2017)

Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Chao, Dong, et al.
Publicado: (2021)

E-cadherin as a prognostic indicator in primary breast cancer
por: Parker, C, et al.
Publicado: (2001)

Prognostic significance of E-cadherin expression in prostatic carcinoma: A protocol for systematic review and meta-analysis
por: Zhang, Xiwen, et al.
Publicado: (2020)

Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
por: Ku, Su-Chi, et al.
Publicado: (2022)

Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
por: Gao, Minna, et al.
Publicado: (2016)

Expression and prognostic values of ARID family members in breast cancer
por: Zhang, Jinfeng, et al.
Publicado: (2021)

Progression of Oral Squamous Cell Carcinoma Accompanied with Reduced E-Cadherin Expression but Not Cadherin Switch
por: Hashimoto, Takashi, et al.
Publicado: (2012)

Phosphorylation of E-cadherin at threonine 790 by protein kinase Cδ reduces β-catenin binding and suppresses the function of E-cadherin
por: Chen, Chien-Lin, et al.
Publicado: (2016)

Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis
por: Wang, Pengbo, et al.
Publicado: (2021)

Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Yang, Yan-Long, et al.
Publicado: (2014)

Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma
por: Rajkumar, Sharmilla Devi, et al.
Publicado: (2021)

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
por: Adamo, Barbara, et al.
Publicado: (2017)

N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression
por: Nieman, Marvin T., et al.
Publicado: (1999)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancer
por: Qiu, Zhi-Xin, et al.
Publicado: (2015)

Prognostic significance of E-cadherin/catenin complex expression in gastric cancer.
por: Joo, Y. E., et al.
Publicado: (2000)

The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis
por: Yin, Songcheng, et al.
Publicado: (2017)

αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer
por: de Groot, Jolien S, et al.
Publicado: (2018)

In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin
por: Batistatou, A, et al.
Publicado: (2007)

Significance of E-cadherin expression in triple-negative breast cancer
por: Kashiwagi, S, et al.
Publicado: (2010)

The role of E-Cadherin expression in primary site of breast cancer
por: Karsten, Nora, et al.
Publicado: (2021)

Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2017)

Abnormal Expression of Serum Soluble E-Cadherin is Correlated with Clinicopathological Features and Prognosis of Breast Cancer
por: Liang, Zhi, et al.
Publicado: (2014)

Association of quantitative analysis of intratumoral reduced E-cadherin expression with lymph node metastasis and prognosis in patients with breast cancer
por: Meng, Xiangyue, et al.
Publicado: (2023)

Diagnostic value and prognostic significance of LI-cadherin and miR-378e in colorectal cancer
por: Wang, Xujie, et al.
Publicado: (2020)

E‐cadherin deregulation in breast cancer
por: Corso, Giovanni, et al.
Publicado: (2020)

Potential value of circulatory microRNA10b gene expression and its target E‐cadherin as a prognostic and metastatic prediction marker for breast cancer
por: Dwedar, Fatma Ibrahim, et al.
Publicado: (2021)

Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2019)

TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival
por: Liu, Weiguang, et al.
Publicado: (2017)

E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
por: Christgen, Matthias, et al.
Publicado: (2020)

E-cadherin expression in primary carcinomas of the breast and its distant metastases
por: Kowalski, Paul J, et al.
Publicado: (2003)

Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer
por: Park, Sang Yoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6f54ik9ab75daou2gs2okrd71q